slide deck (pdf) - CME Outfitters
slide deck (pdf) - CME Outfitters slide deck (pdf) - CME Outfitters
What percentage of your patients with benign prostatic hyperplasia (with or without concomitant erectile dysfunction) do you treat in accordance with recommendations from the American Urological Association (AUA)? A. 0% B. 1% - 25% Pre-symposium Question #2 C. 26% - 50% D. 51% - 75% E. 76% - 100%
Function of the Prostate Normal Function ! Produces fluid for seminal emission ! Does not grow into the urethra thereby allowing unobstructed flow Abnormal Function ! Obstruction of urinary flow ! Poor function seen as failure to void Rosenberg MT, et al. Int J Clin Pract. 2007;61(9):1535-1546. PMID: 17627768.
- Page 1 and 2: Gaining Ground in Men’s Genitouri
- Page 3 and 4: Accreditation This program has been
- Page 5 and 6: Learning Objectives ! Explain the s
- Page 7 and 8: Matt T. Rosenberg, MD Disclosures S
- Page 9 and 10: Disclosures ! Faculty of this CE ac
- Page 11 and 12: Get Social with Us CMEOutfitters.co
- Page 13 and 14: Georgia Association of Physician As
- Page 15 and 16: Matt T. Rosenberg, MD Disclosures S
- Page 17: In what percentage of your patients
- Page 21 and 22: Benign Prostatic Hyperplasia ! A co
- Page 23 and 24: Predominant Symptoms ! The enlarged
- Page 25 and 26: Definition of OAB International Con
- Page 27 and 28: How to differentiate the etiology o
- Page 29 and 30: Common Comorbidities in BPH-LUTS Co
- Page 31 and 32: Audience Response Question Fact: ED
- Page 33 and 34: BPH-LUTS and ED Common Pathophysiol
- Page 35 and 36: What to Keep in Mind in the Evaluat
- Page 37 and 38: The Evaluation of LUTS: History, Ph
- Page 39 and 40: Medications Can Cause or Exacerbate
- Page 41 and 42: Laboratory Tests ! Urinalysis ! Inf
- Page 43 and 44: Audience Response Question The most
- Page 45 and 46: The Purpose of the Voiding Diary !
- Page 47 and 48: Rosenberg MT, et al. Publication Pe
- Page 49 and 50: STEP 1: Informed Surveillance If th
- Page 51 and 52: Clinical Management Step2a: Alpha B
- Page 53 and 54: Clinical Management Step2b: Phospho
- Page 55 and 56: Rosenberg MT, et al. Publication Pe
- Page 57 and 58: Antimuscarinics - Immediate Release
- Page 59 and 60: ! Dry Mouth ! Constipation ! Headac
- Page 61 and 62: Beta 3 Agonists Drug Mirabegron Dos
- Page 63 and 64: Clinical Management Step3b: Adding
- Page 65 and 66: 5 Alpha Reductase Inhibitors (5ARI)
- Page 67 and 68: Rosenberg MT, et al. Publication Pe
What percentage of your patients with<br />
benign prostatic hyperplasia (with or without<br />
concomitant erectile dysfunction) do you<br />
treat in accordance with recommendations<br />
from the American Urological Association<br />
(AUA)?<br />
A. 0%<br />
B. 1% - 25%<br />
Pre-symposium Question #2<br />
C. 26% - 50%<br />
D. 51% - 75%<br />
E. 76% - 100%
Change language